Table 1 The clinicopathology features and survival time distribution of MB patients
MB | Number of patients | Median survival times | P value |
|---|---|---|---|
44 cases | (Death) | X ± s (months) | (<0.05) |
Sex | 0.346 | ||
Male | 27(19) | 15 ± 5.769 | |
Female | 17(12) | 24 ± 11.406 | |
Resection stage | |||
Total resection | 33(17) | 35 ± 4.763 | 0.0352 |
Partial resection | 11(9) | 20 ± 6.020 | |
Therapy | <0.0001 | ||
Surgery only | 27(23) | 10 ± 0.975 | |
Surgery + Radiotherapy | 17(3) | 53 ± 10.29 | |
Ki67 | 0.051 | ||
0,1+, 2+ | 21(8) | 51 ± 10.29 | |
3+ | 13(8) | 20 ± 5.503 | |
EGFR (IHC) (34 cases) | 0.0001 | ||
0,1+, 2+ | 20(5) | 53 ± 20.82 | |
3+ | 14(11) | 11 ± 3.338 | |
EGFR (FISH) (34 cases) | 0.002 | ||
Negative | 15(5) | 53 ± 19.96 | |
Positive | 19(11) | 20 ± 7.028 |